Learning the Points of COMPASS-HF. Assessing Implantable Hemodynamic Monitoring in Heart Failure Patients**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 51, Issue 11, 2008, Pages 1080-1082

  Teerlink, John R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

EDITORIAL; HEALTH CARE; HEART ASSIST DEVICE; HEART FAILURE; HEART HEMODYNAMICS; HOSPITAL CARE; HOSPITAL COST; HUMAN; IMPLANT; PATIENT MONITORING; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

BLOOD PRESSURE DETERMINATION; BLOOD PRESSURE MONITORS; HEART FAILURE; HEMODYNAMICS; HUMANS; MONITORING, PHYSIOLOGIC; PROSTHESES AND IMPLANTS; VENTRICULAR PRESSURE;

EID: 40649103913     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.12.009     Document Type: Editorial

References (18)

1. Thoreau, HD. Chapter 8. The Village. In: Walden;1854:118.
2. American Heart Association. Heart Disease and Stroke Statistics 3-2007 Update (2007), American Heart Association, Dallas, Texas
3. Stevenson L.W., and Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261 (1989) 884-888
4. Wolfel E.E. Can we predict and prevent the onset of acute decompensated heart failure?. Circulation 116 (2007) 1526-1529
5. Cuffe M.S., Califf R.M., Adams Jr. K.F., et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial. JAMA 287 (2002) 1541-1547
6. Konstam M.A., Gheorghiade M., Burnett Jr. J.C., et al. Effects of oral tolvaptan in patients hospitalized for worsening heart failure: the EVEREST Outcome Trial. JAMA 297 (2007) 1319-1331
7. McMurray J.J., Teerlink J.R., Cotter G., et al. Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials. JAMA 298 (2007) 2009-2119
8. Costanzo M.R., Guglin M.E., Saltzberg M.T., et al. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure. J Am Coll Cardiol 49 (2007) 675-683
9. Butler J., Young J.B., Abraham W.T., et al. Beta-blocker use and outcomes among hospitalized heart failure patients. J Am Coll Cardiol 47 (2006) 2462-2469
10. Göhler A., Januzzi J.L., Worrell S.S., et al. A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. J Card Fail 12 (2006) 554-567
11. Jourdain P., Jondeau G., Funck F., et al. Plasma brain natriuretic peptide-guided therapy to improve outcome in heart failure: the STARS-BNP multicenter study. J Am Coll Cardiol 49 (2007) 1733-1739
12. Chaudhry S.I., Phillips C.O., Stewart S.S., et al. Telemonitoring for patients with chronic heart failure: a systematic review. J Card Fail 13 (2007) 56-62
13. Chaudhry S.I., Wang Y., Concato J., Gill T.M., and Krumholz H.M. Patterns of weight change preceding hospitalization for heart failure. Circulation 116 (2007) 1549-1554
14. Goldberg L.R., Piette J.D., Walsh M.N., et al. Randomized trial of a daily electronic home monitoring system in patients with advanced heart failure: the Weight Monitoring in Heart Failure (WHARF) trial. Am Heart J 146 (2003) 705-712
15. Packer M., Abraham W.T., Mehra M.R., et al. Utility of impedance cardiography for the identification of short-term risk of clinical decompensation in stable patients with chronic heart failure. J Am Coll Cardiol 47 (2006) 2245-2252
16. Yu C.M., Wang L., Chau E., et al. Intrathoracic impedance monitoring in patients with heart failure: correlation with fluid status and feasibility of early warning preceding hospitalization. Circulation 112 (2005) 841-848
17. Bourge R.C., Abraham W.T., Adamson P.B., et al. Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 51 (2008) 1073-1079
18. Magalski A., Adamson P., Gadler F., et al. Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: a multicenter, 12-month follow-up study of patients with chronic heart failure. J Card Fail 8 (2002) 63-70